The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.

Abstract: The current source converter (CSC) is a competitive solution for offshore wind grid integration. The fundamental frequency modulation-based current source converter (FFM-CSC) effectively ...

Disclaimer: Trastuzumab deruxtecan has not been approved by the FDA for the neoadjuvant or adjuvant setting for early-stage, ...

The Buffalo Bills are normally plenty aggressive. On Sunday against the New England Patriots, though, head coach Sean McDermott was the opposite. Twice, the Bills had a fourth down and less than 10 ...

SAN ANTONIO -- Preoperative radiotherapy (RT) plus PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune ...

Abstract: The problem of voltage imbalance propagation in an inverter-based islanded multi-microgrid consists of avoiding the propagation of the voltage imbalance generated within one microgrid to the ...